RTsafe and JW Pacific sign a distribution agreement
Athens, Greece - Sept. 2, 2019 - RTsafe, a medical technology company focused on improving the safety and accuracy of radiotherapy for cancer and other medical conditions, today announced that it has signed JW Pacific as its exclusive distributor for Hong Kong, Macau, Taiwan & South Korea.
Based in Hong Kong, JW Pacific, specializes in providing quality assurance software and phantoms to radiotherapy and diagnostic radiology customers in the Asia-Pacific region. With over two decades of experience in the radiotherapy field, JW Pacific seamlessly integrates quality assurance products to meet challenges in QA.
RTsafe is a medical technology company that has developed a unique approach to quality assurance that significantly enhances the safety and accuracy of radiotherapy for cancer and other medical conditions. It combines proven expertise in medical physics with highly accurate 3D printing technology to create pseudo‐in‐vivo dosimetry phantoms towards End‐to‐End commissioning, benchmarking and patient‐specific quality assurance in SRS, IMRT, VMAT and SBRT applications. The anatomically accurate effigies enable medical professionals to plan more precise treatment interventions for each individual patient and help radiotherapy technology innovators to fine‐tune their products. The result is more effective individualized therapy and reduced patient risk. For more information, visit www.rt-safe.com.